138 related articles for article (PubMed ID: 1677234)
1. The biology of bone marrow transplantation for severe combined immune deficiency.
Parkman R
Adv Immunol; 1991; 49():381-410. PubMed ID: 1677234
[No Abstract] [Full Text] [Related]
2. Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.
Nespoli L; Porta F; Locatelli F; Aversa F; Carotti A; Lanfranchi A; Gibardi A; Marchesi ME; Abate L; Martelli MF
Haematologica; 1990; 75(6):546-50. PubMed ID: 2098297
[TBL] [Abstract][Full Text] [Related]
3. Immunological reconstitution after HLA-haploidentical bone marrow transplantation for SCID in an infant with ADA deficiency.
Lanfranchi A; Nespoli L; Porta F; Martelli MF; Aversa F; Bonetti F; Locatelli F; Gibardi A; Martinetti M; Burgio GR
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():168-70. PubMed ID: 2627620
[No Abstract] [Full Text] [Related]
4. Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution.
Porta F; Locatelli F; Burgio GR
Haematologica; 2008 Nov; 93(11):1607-10. PubMed ID: 18978297
[No Abstract] [Full Text] [Related]
5. Donor type natural killer cells after haploidentical T cell-depleted bone marrow stem cell transplantation in a patient with adenosine deaminase-deficient severe combined immunodeficiency.
Gaines AD; Schiff SE; Buckley RH
Clin Immunol Immunopathol; 1991 Aug; 60(2):299-304. PubMed ID: 1712689
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation for the treatment of immune deficiency states.
Lenarsky C; Parkman R
Bone Marrow Transplant; 1990 Dec; 6(6):361-9. PubMed ID: 1965792
[TBL] [Abstract][Full Text] [Related]
8. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
[No Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
10. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome").
Casper JT; Ash RA; Kirchner P; Hunter JB; Havens PL; Chusid MJ
J Pediatr; 1990 Feb; 116(2):262-5. PubMed ID: 2299498
[TBL] [Abstract][Full Text] [Related]
12. Primary immunodeficiencies: molecular aspects and treatment.
Fischer A
Bone Marrow Transplant; 1992; 9 Suppl 1():39-43. PubMed ID: 1354525
[No Abstract] [Full Text] [Related]
13. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
14. Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency.
Rosenkrantz K; Keever C; Bhimani K; Horvath A; Brochstein J; O'Reilly R; Dupont B; Flomenberg N
J Immunol; 1990 Mar; 144(5):1721-8. PubMed ID: 2307837
[TBL] [Abstract][Full Text] [Related]
15. Primary T-cell immunodeficiencies.
Fischer A
Curr Opin Immunol; 1993 Aug; 5(4):569-78. PubMed ID: 8216933
[TBL] [Abstract][Full Text] [Related]
16. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
17. Treatment of immunodeficiency diseases by organ transplantation.
Parkman R
Prog Clin Immunol; 1977; 3():85-102. PubMed ID: 17139
[No Abstract] [Full Text] [Related]
18. [Bone marrow transplantation in the primary immunodeficiencies].
Madero López L; Villa Alcázar M
Sangre (Barc); 1999 Apr; 44(2):135-41. PubMed ID: 10382323
[No Abstract] [Full Text] [Related]
19. Overview of immunodeficiency diseases where bone marrow transplantation is feasible.
Nelson DL; Notarangelo LD
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():132. PubMed ID: 2516752
[No Abstract] [Full Text] [Related]
20. Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.
Silber GM; Winkelstein JA; Moen RC; Horowitz SD; Trigg M; Hong R
Clin Immunol Immunopathol; 1987 Sep; 44(3):317-20. PubMed ID: 3304740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
